Human Clinical Trials on Anti-Aging Compound Derived From Pomegranates Show Promising Results

Human clinical trials show promise for a pomegranate-derived anti-aging compound

Targeting aging, which is the main driver of many diseases could be an effective way to treat a wide range of illnesses and improve quality of life. Researchers at EPFL reported that a fruit-derived substance showed promise in human clinical trials in slowing mitochondrial ageing in elderly patients.


Leave a Reply

Your email address will not be published. Required fields are marked *